Healthcare provider profile · identity verified

David Morland

Physician Assistant · GALVA, IL · NPI 1720178007

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	310	84
Levothyroxine Sodium	Levothyroxine Sodium	294	73
Losartan Potassium	Losartan Potassium	292	84
Omeprazole	Omeprazole	245	63
Lisinopril	Lisinopril	219	58
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	216	41
Amlodipine Besylate	Amlodipine Besylate	215	57
Simvastatin	Simvastatin	203	49
Furosemide	Furosemide	196	57
Tramadol Hcl	Tramadol Hcl	190	47
Potassium Chloride	Potassium Chloride	189	45
Sertraline Hcl	Sertraline Hcl	171	45
Meloxicam	Meloxicam	163	43
Lorazepam	Lorazepam	155	37
Hydrochlorothiazide	Hydrochlorothiazide	153	35
Metoprolol Succinate	Metoprolol Succinate	146	44
Pantoprazole Sodium	Pantoprazole Sodium	146	38
Albuterol Sulfate Hfa	Albuterol Sulfate	137	39
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	137	38
Prednisone	Prednisone	134	78
Clopidogrel	Clopidogrel Bisulfate	121	28
Metformin Hcl Er	Metformin Hcl	110	32
Allopurinol	Allopurinol	109	24
Alprazolam	Alprazolam	108	16
Warfarin Sodium	Warfarin Sodium	102	27
Metoprolol Tartrate	Metoprolol Tartrate	100	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	99	24
Gabapentin	Gabapentin	98	26
Eliquis	Apixaban	93	19
Atenolol	Atenolol	85	22
Glipizide Er	Glipizide	78	19
Tamsulosin Hcl	Tamsulosin Hcl	78	23
Azithromycin	Azithromycin	77	48
Trazodone Hcl	Trazodone Hcl	76	19
Cephalexin	Cephalexin	75	54
Pravastatin Sodium	Pravastatin Sodium	66	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	13
Zolpidem Tartrate	Zolpidem Tartrate	57	11
Carvedilol	Carvedilol	53	17
Doxycycline Hyclate	Doxycycline Hyclate	53	45
Ropinirole Hcl	Ropinirole Hcl	51	suppressed
Mounjaro	Tirzepatide	50	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	46	11
Alendronate Sodium	Alendronate Sodium	44	12
Escitalopram Oxalate	Escitalopram Oxalate	44	12
Fluoxetine Hcl	Fluoxetine Hcl	43	13
Methylprednisolone	Methylprednisolone	42	42
Rosuvastatin Calcium	Rosuvastatin Calcium	42	15
Spironolactone	Spironolactone	42	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	36
Citalopram Hbr	Citalopram Hydrobromide	40	11
Metformin Hcl	Metformin Hcl	39	13
Triamcinolone Acetonide	Triamcinolone Acetonide	39	23
Donepezil Hcl	Donepezil Hcl	38	13
Ezetimibe	Ezetimibe	38	13
Januvia	Sitagliptin Phosphate	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Klor-Con M20	Potassium Chloride	32	11
Clonazepam	Clonazepam	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Celecoxib	Celecoxib	29	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	28	suppressed
Ozempic	Semaglutide	28	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Glipizide	Glipizide	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Famotidine	Famotidine	26	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Finasteride	Finasteride	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Fluticasone Propionate	Fluticasone Propionate	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	16
Ondansetron Odt	Ondansetron	18	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Single Use Swab	Alcohol Antiseptic Pads	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	14	12
Diazepam	Diazepam	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Temazepam	Temazepam	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Cefuroxime	Cefuroxime Axetil	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error